Primary Sclerosing Cholangitis Clinical Trials

27 recruiting

Primary Sclerosing Cholangitis Trials at a Glance

24 actively recruiting trials for primary sclerosing cholangitis are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Phase 2 with 6 trials, with the heaviest enrollment activity in Cincinnati, Seattle, and Rochester. Lead sponsors running primary sclerosing cholangitis studies include Children's Hospital Medical Center, Cincinnati, Mayo Clinic, and University of Milano Bicocca.

Browse primary sclerosing cholangitis trials by phase

Treatments under study

About Primary Sclerosing Cholangitis Clinical Trials

Looking for clinical trials for Primary Sclerosing Cholangitis? There are currently 27 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Primary Sclerosing Cholangitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Primary Sclerosing Cholangitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting
Phase 2

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

Inflammatory Bowel DiseasesPrimary Sclerosing Cholangitis
University of Birmingham58 enrolled5 locationsNCT06286709
Recruiting

Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach

Primary Sclerosing Cholangitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)143 enrolled1 locationNCT04685200
Recruiting

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Non-Alcoholic Fatty Liver DiseaseAutoimmune HepatitisPrimary Sclerosing Cholangitis+2 more
Chungnam National University Hospital3,000 enrolled1 locationNCT06519162
Recruiting
Phase 1

A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)

Healthy VolunteersPrimary Sclerosing Cholangitis
Takeda134 enrolled1 locationNCT07229911
Recruiting
Early Phase 1

Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study

Inflammatory Bowel DiseasesPrimary Sclerosing Cholangitis
Stanford University15 enrolled1 locationNCT05912387
Recruiting

Biobank for Cholestatic Liver Diseases.

Liver CancerCholangiocarcinomaPrimary Sclerosing Cholangitis+1 more
Mayo Clinic9,150 enrolled1 locationNCT03445585
Recruiting

Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients

CholangiocarcinomaPrimary Sclerosing CholangitisPSC
Mayo Clinic300 enrolled1 locationNCT04753996
Recruiting
Phase 1

A Study of SIPLIZUMAB in AILD and LT Patients

Autoimmune HepatitisPrimary Sclerosing CholangitisLiver Transplant Disorder+1 more
Elizabeth C. Verna8 enrolled1 locationNCT06455280
Recruiting
Phase 2

Detoxification of the Liver In PSC (Dolphin)

Primary Sclerosing Cholangitis
Brigham and Women's Hospital28 enrolled1 locationNCT05835505
Recruiting
Phase 2

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

Primary Sclerosing Cholangitis (PSC)
LISCure Biosciences87 enrolled7 locationsNCT06699121
Recruiting

Primary Sclerosing Cholangitis in Children

Liver DiseasesPrimary Sclerosing CholangitisCholangitis, Sclerosing
Arbor Research Collaborative for Health1,000 enrolled12 locationsNCT04181138
Recruiting

Swiss Primary Sclerosing Cholangitis Cohort Study

Primary Sclerosing Cholangitis (PSC)Cholangitis, SclerosingPSC
Fondazione Epatocentro Ticino120 enrolled21 locationsNCT03146936
Recruiting
Phase 2

Vancomycin in Primary Sclerosing Cholangitis in Italy

Primary Sclerosing CholangitisIBDLiver and Intrahepatic Bile Duct Disorder
University of Milano Bicocca84 enrolled1 locationNCT05876182
Recruiting

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Autoimmune HepatitisPrimary Sclerosing Cholangitis
Children's Hospital Medical Center, Cincinnati800 enrolled8 locationsNCT05750498
Recruiting
Phase 2

Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

Primary Sclerosing Cholangitis
Mayo Clinic80 enrolled1 locationNCT06905054
Recruiting
Phase 2

Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.

Primary Sclerosing Cholangitis
Aparna Goel24 enrolled2 locationsNCT05295680
Recruiting

LEOPARD Training and Validation Data Collection Study

Primary Biliary CholangitisPrimary Sclerosing CholangitisDecompensated Liver Cirrhosis
Assistance Publique - Hôpitaux de Paris4,500 enrolled22 locationsNCT06675604
Recruiting
Early Phase 1

Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC

Primary Sclerosing Cholangitis
University of Minnesota28 enrolled1 locationNCT06197308
Recruiting

Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)

Primary Sclerosing Cholangitis (PSC)Primary Biliary Cholangitis (PBC)Hepatitis Autoimmune Disease+1 more
Asociación Española para el Estudio del Hígado5,000 enrolled1 locationNCT06767605
Recruiting

MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease

Autoimmune HepatitisPrimary Sclerosing CholangitisAutoimmune Liver Disease
Children's Hospital Medical Center, Cincinnati150 enrolled1 locationNCT03178630